/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Catalyst Pharmaceutical Partners Inc.\n \n\n\n\n\n
Nov 23 6:49 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 13, 2009 5:35 PM EST
\n\n \n Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement - PR Newswire\n \n \n
\n\n Nov 12, 2009 8:03 AM EST
\n\n \n Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results - PR Newswire\n \n \n
\n\n Nov 12, 2009 8:03 AM EST
\n\n \n /C O R R E C T I O N -- Catalyst Pharmaceutical Partners, Inc./ - PR Newswire\n \n \n
\n\n Nov 10, 2009 8:03 AM EST
\n\n \n U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain - PR Newswire\n \n \n
\n\n Oct 13, 2009 8:03 AM EDT
\n\n \n Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executive's Employment Agreement - PR Newswire\n \n \n
\n\n Oct 06, 2009 5:17 PM EDT
\n\n \n Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering - PR Newswire\n \n \n
\n\n Oct 01, 2009 5:58 PM EDT
\n\n \n Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering - PR Newswire\n \n \n
\n
\n\n");